BDTB 10-K & 10-Q changes, risk factors and insider trading
Bodhi Tree Biotechnology Inc · OTC · Services-Management Consulting Services · CIK 2041531 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
As a smaller reporting company, we are not required to make disclosures under this Item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
We recordedsee in full comparison$95,883$129,078 and$121,956$141,931 in selling, general and administrative expenses for thesixnine months endedMarchJune31,30, 2026 and 2025. These costs mainly consist of professional service from our law firm, auditor and accountant, and payment to OCTOB etc.
As a result of the above factors, we had a net loss ofsee in full comparison$82,144$105,338 and$118,205$138,979 for thesixnine months endedMarchJune31,30, 2026 and 2025.
We recordedsee in full comparison$42,934$33,195 and$52,179$19,975 in selling, general and administrative expenses for the three months endedMarchJune31,30, 2026 and 2025. These costs mainly consist of professional service fromfromour law firm, auditor and accountant, and payment to OCTOB etc.
As a result of the above factors, we had a net loss ofsee in full comparison$29,195$23,194 and$53,428$20,774 for the three months endedMarchJune31,30, 2026 and 2025.
Net cash used in operating activities for thesee in full comparisonthreenine months endedMarchJune31,30, 2026totalledtotaled$86,654.$105,418. Operating activities consisted primarily of net loss adjusted for certain non-cash items. In addition, operating cash flows included the effect of changes in operating assets and liabilities. Cash used during the period is mainly relating to payment to professional accounting firm and law firm, and relating operating expense, such as rent, payment to director, bookkeeper, etc.
Full comparison: every changed paragraph (15)
Comparison of the sixnine months ended MarchJune 31,30,
2026 and 2025
Revenues were $15,000$25,000 and $5,000 for the sixnine months
ended MarchJune 31,30, 2026 and 2025.
Cost of revenue was $nil for the sixnine months ended
MarchJune 31,30, 2026 and 2025.
We recorded $95,883$129,078 and $121,956$141,931 in selling, general
and administrative expenses for the sixnine months ended MarchJune 31,30, 2026 and 2025. These costs mainly consist of professional service
from our law firm, auditor and accountant, and payment to OCTOB etc.
As a result of the above factors, we had a net
loss of $82,144$105,338 and $118,205$138,979 for the sixnine months ended MarchJune 31,30, 2026 and 2025.
Comparison of the three months ended MarchJune 31,30,
2026 and 2025
Revenues were $15,000$10,000 and $nil for the three months
ended MarchJune 31,30, 2026 and 2025.
Cost of revenue was $nil for the three months
ended MarchJune 31,30, 2026 and 2025.
We recorded $42,934$33,195 and $52,179$19,975 in selling, general
and administrative expenses for the three months ended MarchJune 31,30, 2026 and 2025. These costs mainly consist of professional service from
from our law firm, auditor and accountant, and payment to OCTOB etc.
As a result of the above factors, we had a net
loss of $29,195$23,194 and $53,428$20,774 for the three months ended MarchJune 31,30, 2026 and 2025.
Net cash used in operating activities for the
threenine months ended MarchJune 31,30, 2026 totalledtotaled $86,654.$105,418. Operating activities consisted primarily of net loss adjusted for certain non-cash
items. In addition, operating cash flows included the effect of changes in operating assets and liabilities. Cash used during the period
is mainly relating to payment to professional accounting firm and law firm, and relating operating expense, such as rent, payment to director,
bookkeeper, etc.
There were no investing activities for the threenine
months ended MarchJune 31,30, 2026 and 2025.
There were no financing activities for the threenine
months ended MarchJune 31,30, 2026 and 2025.
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of SeptemberJune 30, 2025.2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
As of SeptemberJune 30, 2025,2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.
BDTB insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding BDTB (13F)
None of the 59 investors we track reported a position in their latest 13F.